HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Marra Selected Research

MiCMA protocol

2/2006Mitoxantrone, carboplatin, cytosine arabinoside, and methylprednisolone followed by autologous peripheral blood stem cell transplantation: a salvage regimen for patients with refractory or recurrent non-Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Marra Research Topics

Disease

1Lymphoma (Lymphomas)
12/2009
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2006
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2006

Drug/Important Bio-Agent (IBA)

1Methotrexate (Mexate)FDA LinkGeneric
12/2009
1Mitoxantrone (Novantrone)FDA LinkGeneric
02/2006
1Carboplatin (JM8)FDA LinkGeneric
02/2006
1Cytarabine (Cytosar-U)FDA LinkGeneric
02/2006
1MethylprednisoloneFDA LinkGeneric
02/2006

Therapy/Procedure

2Drug Therapy (Chemotherapy)
12/2009 - 02/2006
1Radiotherapy
12/2009
1MiCMA protocol
02/2006
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2006